FDA warns of foot, leg amputations with J & J diabetes drug
(Reuters) - Johnson& Johnson is required to add new warnings to its diabetes drug, Invokana, about the risk of foot and leg amputations, the U.S. Food and Drug Administration said on Tuesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Canagliflozin | Diabetes | Endocrinology | Food and Drug Administration (FDA) | Health | Invokana | Warnings